Article

Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer.
Bassoy, E.Y., Raja, R., Rubino, T.E., Coscia, F. ORCID: https://orcid.org/0000-0002-2244-5081, Goergen, K., Magtibay, P., Butler, K., Schmitt, A., Oberg, A.L. and Curtis, M. ORCID: https://orcid.org/0000-0002-7152-6929
OncoImmunology 14 (1): 2460276. 31 January 2025

Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis.
Frueh, J.T., Campe, J., Sunaga-Franze, D.Y. ORCID: https://orcid.org/0000-0002-6851-9162, Verheyden, N.A., Ghimire, S., Meedt, E., Haslinger, D., Harenkamp, S., Staudenraus, D., Sauer, S. ORCID: https://orcid.org/0000-0002-4794-3693, Kreft, A., Schubert, R., Lohoff, M., Krueger, A., Bonig, H., Chiocchetti, A.G., Zeiser, R., Holler, E. and Ullrich, E. ORCID: https://orcid.org/0000-0001-8530-1192
OncoImmunology 13 (1): 2296712. 2024

Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade.
Kofla, G., Radecke, C., Frentsch, M., Walther, W. ORCID: https://orcid.org/0000-0003-2884-0231, Stintzing, S., Riess, H., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510 and Na, I.K. ORCID: https://orcid.org/0000-0001-9902-5424
OncoImmunology 11 (1): 2068109. 25 April 2022

Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression.
Pötzsch, M., Berg, E., Hummel, M., Stein, U. ORCID: https://orcid.org/0000-0001-7006-282X, von Winterfeld, M., Jöhrens, K., Rau, B., Daum, S. and Treese, C. ORCID: https://orcid.org/0000-0001-9120-6773
OncoImmunology 9 (1): 1824632. 30 September 2020

Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.
Kaffes, I., Szulzewsky, F. ORCID: https://orcid.org/0000-0001-5710-9590, Chen, Z. ORCID: https://orcid.org/0000-0001-7403-7015, Herting, C.J., Gabanic, B., Velázquez Vega, J.E., Shelton, J., Switchenko, J.M., Ross, J.L., McSwain, L.F., Huse, J.T., Westermark, B., Nelander, S., Forsberg-Nilsson, K., Uhrbom, L., Maturi, N.P., Cimino, P.J., Holland, E.C., Kettenmann, H. ORCID: https://orcid.org/0000-0001-8208-0291, Brennan, C.W., Brat, D.J. and Hambardzumyan, D. ORCID: https://orcid.org/0000-0003-1975-4665
OncoImmunology 8 (11): e1655360. 22 August 2019

Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer.
Penter, L. ORCID: https://orcid.org/0000-0002-9060-0207, Dietze, K., Ritter, J., Lammoglia Cobo, M.F. ORCID: https://orcid.org/0000-0002-0369-0364, Garmshausen, J., Aigner, F., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Hackstein, H., Wienzek-Lischka, S., Blankenstein, T. ORCID: https://orcid.org/0000-0002-3357-4321, Hummel, M., Dornmair, K. and Hansmann, L. ORCID: https://orcid.org/0000-0003-3790-0128
OncoImmunology 8 (6): e1586409. 24 March 2019

Labeling of cell therapies: How can we get it right?
Waiczies, S. ORCID: https://orcid.org/0000-0002-9916-9572, Niendorf, T. ORCID: https://orcid.org/0000-0001-7584-6527 and Lombardi, G.
OncoImmunology 6 (10): e1345403. 20 July 2017

The splenic marginal zone shapes the phenotype of leukemia B cells and facilitates their niche-specific retention and survival.
Stache, V. ORCID: https://orcid.org/0000-0003-3755-6793, Verlaat, L., Gätjen, M., Heinig, K., Westermann, J., Rehm, A. ORCID: https://orcid.org/0000-0001-7490-1950 and Höpken, U.E. ORCID: https://orcid.org/0000-0002-0776-4893
OncoImmunology 6 (6): e1323155. 6 June 2017

Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.
Schirmer, D., Grünewald, T.G.P., Klar, R., Schmidt, O., Wohlleber, D., Rubio, R.A., Uckert, W. ORCID: https://orcid.org/0000-0002-5121-969X, Thiel, U., Bohne, F., Busch, D.H., Krackhardt, A.M., Burdach, S. and Richter, G.H.S.
OncoImmunology 5 (6): e1175795. 25 April 2016

Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA.
Mensali, N., Ying, F., Sheng, V.O.Y., Yang, W., Walseng, E., Kumari, S., Fallang, L.E., Kolstad, A., Uckert, W. ORCID: https://orcid.org/0000-0002-5121-969X, Malmberg, K.J., Waelchli, S. and Olweus, J.
OncoImmunology 5 (5): e1138199. 18 February 2016

HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity.
Nguyen-Hoai, T., Kobelt, D. ORCID: https://orcid.org/0000-0002-9373-0648, Hohn, O., Vu, M.D. ORCID: https://orcid.org/0000-0001-8932-2142, Schlag, P.M., Doerken, B. ORCID: https://orcid.org/0000-0001-7991-3643, Norley, S., Lipp, M. ORCID: https://orcid.org/0000-0002-0087-2672, Walther, W. ORCID: https://orcid.org/0000-0003-2884-0231, Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470 and Westermann, J.
OncoImmunology 1 (9): 1537-1545. 1 December 2012